July 15/July 22, 2002
In Print Photo by Graham Ramsay Focus: Anticancer Compounds Chase Kinase Culprit Studies by Gary Gilliland and his colleagues are testing compounds that block the molecule FLT3, a receptor tyrosine kinase that is mutated in about one third of people with acute myelogenous leukemia (AML), a particularly virulent cancer. If the work leads to a new therapy, it would change the way AML has been treated for the last 20 years. BBS Bulletin HMI World HSTconnector InteliHealth MD-PhD Newsletter MedEd News Mentations On The Brain		Headlines Diabetes Treatment Linked to Increased Blood Pressure in Animal Study Imaging Test May Detect Gene for Genetic Cardiac Disease Early Administration of Clot-buster Drugs May Improve Outcome for Heart Attack Patients Bladder-sparing Procedure Found Effective for Treating Invasive Bladder Cancer Forum Photo by Jeff Cleary It's Not Easy Being Green in the Lab Early on, Jan Schmollinger was interested in both disease-related research and environmental issues. That caused a conflict since laboratory work is not always friendly to the environment. Here he suggests ways it might be made friendlier. Lab Works A multimedia site featuring Harvard Medical research		Spotlight Photo by Graham Ramsay Sleep Seen as Architect of Learning Robert Stickgold and colleagues published two studies recently demonstrating that sleep is needed for optimal learning. Practice never makes perfect without a good snooze. Student Scene Photo by Carol Morton Dental Students Display Research Results Kevin Schack (center), shown with mentor Donald Giddon, presented his research findings in May at the Harvard School of Dental Medicine's student research day. More than 50 people presented their results at the event.

Calendar | Jobs | About HMS | Hospitals | Back Issues | Feedback | Home Copyright 2002 by the President and Fellows of Harvard College